£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

2023-2028 Anti-Viral Nucleotide Polymerase Inhibitor Drugs Outlook China

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 37 days · 37 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 23 August 2026 01 September 2026 10 September 2026 19 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 54 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 37 days • 1 price levels

Days at Price
37 days 0 9 19 28 37 £495 Days at Price

Price Analysis

Most common price: £495 (37 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 37 days

Description

This comprehensive market analysis report examines the latent demand outlook for anti-viral nucleotide polymerase inhibitor drugs across all regions of China, including provinces, autonomous regions, municipalities, special administrative regions, and Taiwan. The study provides potential industry earnings estimates across approximately 1,100 Chinese cities, delivering detailed market forecasts for pharmaceutical professionals, healthcare strategists, and industry analysts. The 2023-2028 outlook equips stakeholders with data-driven insights into regional drug demand patterns, city-level market penetration, and revenue potential across China's diverse geographic markets. This report from ICON Group International enables informed decision-making for pharmaceutical distribution, regulatory planning, and market entry strategies throughout the Chinese anti-viral drug sector.

Key Features

Covers latent demand forecasts for anti-viral nucleotide polymerase inhibitor drugs across all Chinese regions including provinces, autonomous regions, municipalities, and special administrative regions.

Provides potential industry earnings estimates for approximately 1,100 cities throughout China, enabling location-specific market analysis and targeting.

Delivers five-year outlook data from 2023 to 2028, supporting long-term strategic planning and investment decisions in the Chinese pharmaceutical market.

Published by ICON Group International, a recognised provider of market research and industry analysis for global pharmaceutical sectors.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
25 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
95% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs for US Zip Codes
95% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs for US Zip Codes

£490.00 27 Sep 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States
95% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States

£520.00 27 Sep 2026
2023-2028 Nasal Drug Delivery Outlook for China - Market Research
91% match

2023-2028 Nasal Drug Delivery Outlook for China - Market Research

£495.00 28 Sep 2026
2023-2028 Injectable Drug Delivery Devices Outlook China
91% match

2023-2028 Injectable Drug Delivery Devices Outlook China

£495.00 28 Sep 2026
2023-2028 Viral Clearance Services Outlook China
90% match

2023-2028 Viral Clearance Services Outlook China

£495.00 28 Sep 2026
2023-2028 Orphan Diseases Therapeutics CNS China Outlook
90% match

2023-2028 Orphan Diseases Therapeutics CNS China Outlook

£495.00 28 Sep 2026
2023-2028 Acute Agitation Aggression Treatments Outlook China
90% match

2023-2028 Acute Agitation Aggression Treatments Outlook China

£495.00 28 Sep 2026
2023-2028 China Vitamins Supplements Medicines Outlook
90% match

2023-2028 China Vitamins Supplements Medicines Outlook

£495.00 28 Sep 2026
The 2023-2028 Outlook for Hepatitis Drugs in the United States
90% match

The 2023-2028 Outlook for Hepatitis Drugs in the United States

£520.00 27 Sep 2026
Aneurysmal Subarachnoid Hemorrhage Drugs Outlook China 2023-2028
90% match

Aneurysmal Subarachnoid Hemorrhage Drugs Outlook China 2023-2028

£495.00 28 Sep 2026
Emergency Contraceptive Pills China Market Outlook 2023-2028
89% match

Emergency Contraceptive Pills China Market Outlook 2023-2028

£495.00 28 Sep 2026
2023-2028 Hypercalcemia Treatment Outlook for China
89% match

2023-2028 Hypercalcemia Treatment Outlook for China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Pet Veterinary Drugs in China
89% match

The 2023-2028 Outlook for Pet Veterinary Drugs in China

£495.00 15 Sep 2026
2023-2028 Mycotoxin Binders Outlook for China - Market Analysis
89% match

2023-2028 Mycotoxin Binders Outlook for China - Market Analysis

£495.00 28 Sep 2026
China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook
89% match

China Contraceptive Implantable Drug Delivery Devices 2023-2028 Outlook

£495.00 28 Sep 2026
2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China
89% match

2023-2028 Uterine Sarcoma Therapeutics & Diagnostics Outlook - China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
89% match

The 2023-2028 Outlook for Hepatitis Therapeutics in the United States

£520.00 27 Sep 2026
The 2019-2024 Outlook for Antibody Drugs in China
89% match

The 2019-2024 Outlook for Antibody Drugs in China

£446.25 27 Sep 2026
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
89% match

The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes

£490.00 27 Sep 2026
2023-2028 Orphan Diseases Oncology Therapeutics Outlook China
89% match

2023-2028 Orphan Diseases Oncology Therapeutics Outlook China

£495.00 28 Sep 2026
The 2023-2028 Outlook for Antifungal Drugs in India
89% match

The 2023-2028 Outlook for Antifungal Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Liver Cirrhosis Drugs in the United States
89% match

The 2023-2028 Outlook for Liver Cirrhosis Drugs in the United States

£520.00 27 Sep 2026
2023-2028 HPV Vaccines Outlook for China - Market Analysis
88% match

2023-2028 HPV Vaccines Outlook for China - Market Analysis

£495.00 29 Sep 2026